Get the Stockscreener App
25.83
0.23%
0.06
After Hours:
25.82
-0.010
-0.04%
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc stock is traded at $25.83, with a volume of 27.38M.
It is up +0.23% in the last 24 hours and down -9.21% over the past month.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
See More
Previous Close:
$25.77
Open:
$25.76
24h Volume:
27.38M
Relative Volume:
0.77
Market Cap:
$146.72B
Revenue:
$59.37B
Net Income/Loss:
$4.25B
P/E Ratio:
14.11
EPS:
1.83
Net Cash Flow:
$8.23B
1W Performance:
+3.57%
1M Performance:
-9.21%
6M Performance:
-10.56%
1Y Performance:
-14.30%
1-Day Range:
$25.70
$25.95
1-Week Range:
$24.77
$26.45
52-Week Range:
$24.48
$31.54
Pfizer Inc Stock (PFE) Company Profile
Name
Pfizer Inc
Sector
Industry
Phone
(212) 733-2323
Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
25.83 | 146.72B | 59.37B | 4.25B | 8.23B | 1.83 |
|
LLY
Lilly Eli Co
|
788.19 | 752.65B | 40.86B | 8.37B | -2.28B | 5.4193 |
|
NVO
Novo Nordisk Adr
|
106.13 | 471.56B | 39.36B | 13.79B | 9.83B | 2.4077 |
|
JNJ
Johnson Johnson
|
155.40 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
|
ABBV
Abbvie Inc
|
183.08 | 323.72B | 55.53B | 5.12B | 15.62B | 3.65 |
|
MRK
Merck Co Inc
|
103.12 | 260.72B | 63.17B | 12.15B | 14.84B | 1.80 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-25-24 | Resumed | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Aug-07-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Mar-22-24 | Downgrade | Argus | Buy → Hold |
| Feb-23-24 | Initiated | Guggenheim | Buy |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Oct-20-23 | Resumed | UBS | Neutral |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Neutral |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Jun-29-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-11-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Mar-06-23 | Initiated | Jefferies | Hold |
| Feb-07-23 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-26-23 | Downgrade | UBS | Buy → Neutral |
| Jan-17-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-04-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-03-22 | Reiterated | Bernstein | Mkt Perform |
| Dec-20-21 | Reiterated | Cowen | Outperform |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Upgrade | UBS | Neutral → Buy |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Jul-27-21 | Resumed | Truist | Buy |
| May-06-21 | Downgrade | Mizuho | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Feb-04-21 | Upgrade | DZ Bank | Hold → Buy |
| Dec-16-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-19-20 | Resumed | Goldman | Neutral |
| Nov-10-20 | Resumed | Bernstein | Mkt Perform |
| Oct-12-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-16-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-27-20 | Upgrade | Standpoint Research | Hold → Buy |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Outperform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Jul-30-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-30-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-19 | Resumed | Morgan Stanley | Overweight |
| Feb-20-19 | Resumed | Citigroup | Neutral |
| Jan-31-19 | Upgrade | Argus | Hold → Buy |
| Jan-31-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-23-19 | Downgrade | UBS | Buy → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-01-18 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
View All
Pfizer Inc Stock (PFE) Latest News
Pfizer (NYSE:PFE) Trading Up 0.3%Should You Buy? - MarketBeat
Pfizer wins lawsuit - JD Supra
Pfizer Inc. (NYSE:PFE) Shares Sold by MetLife Investment Management LLC - MarketBeat
Which is a Better Buy: Moderna or Pfizer? - Baystreet.ca
Healthcare of Ontario Pension Plan Trust Fund Boosts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Clifford Capital Partners LLC Purchases 51,703 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Townsquare Capital LLC Has $21.49 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Cadence Bank Has $9.54 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Stock Holdings Cut by The Manufacturers Life Insurance Company - MarketBeat
Dai ichi Life Insurance Company Ltd Has $7.06 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
High-Quality Dividend Growth Stocks Near 52-Week Lows: Pfizer Is Fun - Seeking Alpha
Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead? - Yahoo Finance
John Dorfman: Pfizer, Schlumberger are January Bounce candidates - TribLIVE
Pfizer (NYSE:PFE) Trading Down 1.7%Here's What Happened - MarketBeat
Hypopituitarism Treatment Market to Witness Huge Growth - openPR
PFIZER INC. (PFE) - MSN
$14.58 Bn Meningococcal Vaccines Market Assessment (2023-2034) by Type, Brand, Age Group, Serotype, End-user and Region - GlobeNewswire Inc.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
D.A. Davidson & CO. Raises Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Fisher Asset Management LLC Has $179.72 Million Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Anti infective Agents Market to See Huge Growth by 2024 | Pfizer, Merck, GSK - openPR
Unit Dose Packaging Market Top PlayersPfizer Inc., Amcor Plc, - openPR
Zai Lab, Pfizer team up to widen China access to antibacterial Xacduro - BioWorld Online
Pfizer (NYSE:PFE) Stock Price Up 1.8%Here's Why - MarketBeat
Bridgebio, with FDA approval, faces Pfizer in ATTR - BioWorld Online
Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch
FDA Nod for BridgeBio Brings New Competition to Blockbuster Pfizer Cardio Drug - MedCity News
Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS? - Yahoo! Voices
Pfizer and Schlumberger are January Bounce Candidates - Yahoo Finance
Qsemble Capital Management LP Raises Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Associated Banc Corp Decreases Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Horizon Kinetics Asset Management LLC Acquires 36,370 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
BridgeBio Soars After Drug Gets Nod in Rare Heart Condition - Yahoo Finance
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market - Yahoo Finance
Pfizer And Schlumberger Are January Bounce Candidates - Forbes
BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer - MSN
Independent Advisor Alliance Has $6.79 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Daiwa Securities Group Inc. Acquires 165,611 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Larson Financial Group LLC Has $2.58 Million Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Westfield Capital Management Co. LP Grows Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Great Valley Advisor Group Inc. - MarketBeat
Kingsview Wealth Management LLC Sells 171,822 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
BridgeBio poised to challenge Pfizer after Attruby approval - pharmaphorum
Pfizer Inc. (NYSE:PFE) Shares Sold by Summit Trail Advisors LLC - MarketBeat
Cerity Partners LLC Purchases 412,364 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Segall Bryant & Hamill LLC Purchases New Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Stock Acquired Rep. Laurel M. Lee - MarketBeat
Laurel Lee from Florida's 15th district makes notable trades in Apple, GE Vernova, and Pfizer - Investing.com
Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby - Seeking Alpha
Meridian Wealth Management LLC Takes Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively - Yahoo Finance
Pfizer Inc Stock (PFE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):